188 related articles for article (PubMed ID: 33530461)
41. CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
Szymanska-Pasternak J; Szymanska A; Medrek K; Imyanitov EN; Cybulski C; Gorski B; Magnowski P; Dziuba I; Gugala K; Debniak B; Gozdz S; Sokolenko AP; Krylova NY; Lobeiko OS; Narod SA; Lubinski J
Gynecol Oncol; 2006 Sep; 102(3):429-31. PubMed ID: 16828850
[TBL] [Abstract][Full Text] [Related]
42. Limited relevance of the CHEK2 gene in hereditary breast cancer.
Dufault MR; Betz B; Wappenschmidt B; Hofmann W; Bandick K; Golla A; Pietschmann A; Nestle-Krämling C; Rhiem K; Hüttner C; von Lindern C; Dall P; Kiechle M; Untch M; Jonat W; Meindl A; Scherneck S; Niederacher D; Schmutzler RK; Arnold N
Int J Cancer; 2004 Jun; 110(3):320-5. PubMed ID: 15095295
[TBL] [Abstract][Full Text] [Related]
43. CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
Bayram S; Akkız H; Topaktaş M
Gene; 2013 Jan; 512(2):232-6. PubMed ID: 23107771
[TBL] [Abstract][Full Text] [Related]
44. Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.
Janiszewska H; Bąk A; Skonieczka K; Jaśkowiec A; Kiełbiński M; Jachalska A; Czyżewska M; Jaźwiec B; Kuliszkiewicz-Janus M; Czyż J; Kuliczkowski K; Haus O
Leuk Res; 2018 Jul; 70():74-78. PubMed ID: 29902706
[TBL] [Abstract][Full Text] [Related]
45. Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy.
Banaszkiewicz M; Constantinou M; Pietrusiński M; Kępczyński L; Jędrzejczyk A; Rożniecki M; Marks P; Kałużewski B
Cent European J Urol; 2013; 66(1):23-9. PubMed ID: 24578981
[TBL] [Abstract][Full Text] [Related]
46. CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
Koen K; Robin P; Eline N
Hered Cancer Clin Pract; 2022 Jan; 20(1):5. PubMed ID: 35101071
[TBL] [Abstract][Full Text] [Related]
47. Checkpoint Kinase 2 (CHEK2) Mutation in Renal Cell Carcinoma: A Single-Center Experience.
Huszno J; Kołosza Z
J Kidney Cancer VHL; 2018; 5(1):19-23. PubMed ID: 29682443
[TBL] [Abstract][Full Text] [Related]
48. Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations.
Lizis-Kolus K; Kowalska A; Kozak-Klonowska B; Siołek M; Słuszniak J; Lubiński J; Cybulski C
Endokrynol Pol; 2010; 61(5):502-6. PubMed ID: 21049466
[TBL] [Abstract][Full Text] [Related]
49. CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.
Mohelnikova-Duchonova B; Havranek O; Hlavata I; Foretova L; Kleibl Z; Pohlreich P; Soucek P
Cancer Epidemiol; 2010 Oct; 34(5):656-8. PubMed ID: 20643596
[TBL] [Abstract][Full Text] [Related]
50. Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline
Thibodeau ML; Reisle C; Zhao E; Martin LA; Alwelaie Y; Mungall KL; Ch'ng C; Thomas R; Ng T; Yip S; J Lim H; Sun S; Young SS; Karsan A; Zhao Y; Mungall AJ; Moore RA; J Renouf D; Gelmon K; Ma YP; Hayes M; Laskin J; Marra MA; Schrader KA; Jones SJM
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28514723
[TBL] [Abstract][Full Text] [Related]
51. Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
Heise M; Jarzemski P; Nowak D; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Borysiak M; Pilarska B; Haus O
Cancer Control; 2022; 29():10732748211062342. PubMed ID: 35638715
[No Abstract] [Full Text] [Related]
52. Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study.
Näslund-Koch C; Nordestgaard BG; Bojesen SE
J Clin Oncol; 2016 Apr; 34(11):1208-16. PubMed ID: 26884562
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.
Leedom TP; LaDuca H; McFarland R; Li S; Dolinsky JS; Chao EC
Cancer Genet; 2016 Sep; 209(9):403-407. PubMed ID: 27751358
[TBL] [Abstract][Full Text] [Related]
54. Rapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile Analysis.
Borun P; Salanowski K; Godlewski D; Walkowiak J; Plawski A
Mol Diagn Ther; 2015 Dec; 19(6):419-25. PubMed ID: 26446916
[TBL] [Abstract][Full Text] [Related]
55. Lack of CHEK2 gene mutations in differentiated thyroid carcinoma patients using high resolution melting analysis.
Fayaz S; Fard-Esfahani P; Torbati PM
Asian Pac J Cancer Prev; 2014; 15(12):5019-22. PubMed ID: 24998580
[TBL] [Abstract][Full Text] [Related]
56. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.
Kilpivaara O; Bartkova J; Eerola H; Syrjäkoski K; Vahteristo P; Lukas J; Blomqvist C; Holli K; Heikkilä P; Sauter G; Kallioniemi OP; Bartek J; Nevanlinna H
Int J Cancer; 2005 Feb; 113(4):575-80. PubMed ID: 15472904
[TBL] [Abstract][Full Text] [Related]
57. CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.
Krivokuca A; Dobricic J; Brankovic-Magic M
J BUON; 2013; 18(3):594-600. PubMed ID: 24065469
[TBL] [Abstract][Full Text] [Related]
58. CHEK2 variant I157T may be associated with increased breast cancer risk.
Kilpivaara O; Vahteristo P; Falck J; Syrjäkoski K; Eerola H; Easton D; Bartkova J; Lukas J; Heikkilä P; Aittomäki K; Holli K; Blomqvist C; Kallioniemi OP; Bartek J; Nevanlinna H
Int J Cancer; 2004 Sep; 111(4):543-7. PubMed ID: 15239132
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer.
Ansari N; Shahrabi S; Khosravi A; Shirzad R; Rezaeean H
Lab Med; 2019 Jul; 50(3):e36-e41. PubMed ID: 31220302
[TBL] [Abstract][Full Text] [Related]
60. Current perspectives on CHEK2 mutations in breast cancer.
Apostolou P; Papasotiriou I
Breast Cancer (Dove Med Press); 2017; 9():331-335. PubMed ID: 28553140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
